ImmunoPrecise Antibodies Ltd. (IPA) - Cash per Share

Corporate emblem and logo of ImmunoPrecise Antibodies Ltd. (IPA)

ImmunoPrecise Antibodies (IPA) combines contract antibody discovery with high-yield AI genome analysis to minimize systemic risks. An analysis of cash per share confirms liquidity dynamics, where 0.17 serves as the final level marker. However, the volatility of biotech startup orders and pressure from major CRO contractors create intense competition in molecule development speed, requiring the company to maintain constant technological upgrades.

ImmunoPrecise Antibodies Ltd - IPA Cash per Single Share (period 07/04/2022 - 09/04/2025)

Comprehensive metric breakdowns and analytics for ImmunoPrecise Antibodies (IPA)

- cash position and cash flow details:
Comprehensive company analysis:IPA (ImmunoPrecise Antibodies Ltd.)
Manufactured product of ImmunoPrecise

ImmunoPrecise Antibodies (IPA) is actively modernizing its robotic screening systems and expanding its genomic IT infrastructure. The cash per share history clearly demonstrates the dynamics of liquid reserves available per share. This metric is calculated by dividing total cash by the number of shares outstanding. A decline in this indicator signals either investments in development or capital dilution through secondary offerings. This allows for an objective assessment of the business's financial stability.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology